Trial Review

The ANZCTR website will be unavailable from 1pm until 3pm (AEDT) on Wednesday the 30th of October for website maintenance. Please be sure to log out of the system in order to avoid any loss of data.

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this information for consumers
Trial registered on ANZCTR


Registration number
ACTRN12617000351314
Ethics application status
Approved
Date submitted
3/03/2017
Date registered
8/03/2017
Date last updated
8/03/2017
Type of registration
Prospectively registered

Titles & IDs
Public title
The effect of Chinese herbal medicine on sleep quality in stressed people suffering from insomnia
Scientific title
The use of Chinese herbal formulas for stress related insomnia - pilot study
Secondary ID [1] 291349 0
Nil
Universal Trial Number (UTN)
Trial acronym
HIT
Linked study record

Health condition
Health condition(s) or problem(s) studied:
Insomnia 302333 0
Stress 302334 0
Condition category
Condition code
Alternative and Complementary Medicine 301918 301918 0 0
Herbal remedies
Mental Health 301919 301919 0 0
Anxiety
Neurological 301920 301920 0 0
Other neurological disorders

Intervention/exposure
Study type
Interventional
Description of intervention(s) / exposure
Three groups of participants with 5 in each will be recruited over period of 12 months to confirm the efficacy in this pilot study. A fourth group will receive sham granules.
The participants will need to take 6g of herbal/sham granules twice/day for 14 consecutive days at the participant's home. Herbal granules will be taken orally. Compliance will be recorded using a sleep diary with an intervention compliance tick box.
For the intervention arms participants will be randomised to take one of the following formulas (herbal groups):
1. Chai Hu (Radix Bupleuri), Xiang Fu (Cyperus Tuber), Bai Shao (Paeonia lactiflora Pall) , Zhi Ke (Fructus Citri Aurantii), Chuan Xiong (Ligusticum striatum), and Gan Cao (Glycyrrhiza uralensis Fisch),
2. Chai Hu (Radix Bupleuri), Bai Shao (Paeonia lactiflora Pall), Sheng Di (Radix Rehmanniae) , Du Zhong (Cortex Eucommiae), Fu Shen (Sclerotum Poriae Cocos Paradicis), Suan Zao Ren (Semen Zizyphi Spinosae), Ye Jiao Teng (Caulis Polygoni Multiflori), Dan Sheng (Radix Salviae Miltiorrhizae), Yu Jin (Radix Curcumae)
3. Ye Jiao Teng (Caulis Polygoni Multiflori) and Suan Zao Ren (Semen Zizyphi Spinosae)
Intervention code [1] 297379 0
Treatment: Other
Comparator / control treatment
The control arm will be sham herbal granules which contain only 10% of the dosage of the intervention granules and 90% starch. This is not a placebo and the 10% dosage serves to reinforce blinding of participants and believed to be a non therapeutic dosage.
Control group
Active

Outcomes
Primary outcome [1] 301350 0
Insomnia Severity Index
Timepoint [1] 301350 0
14 days from the commencement of intervention phase
Secondary outcome [1] 332387 0
Depression, Anxiety and Stress Scale (DASS 21)
Timepoint [1] 332387 0
14 days from the commencement of intervention phase
Secondary outcome [2] 332389 0
Digit Span
Timepoint [2] 332389 0
14 days from the commencement of intervention phase
Secondary outcome [3] 332390 0
Chinese Medicine Questionnaire
Timepoint [3] 332390 0
14 days from the commencement of intervention phase
Secondary outcome [4] 332391 0
Fitbit Sleep Data - Sleep duration (measured in minutes)
Timepoint [4] 332391 0
14 days from the commencement of intervention phase

Eligibility
Key inclusion criteria
Insomnia lasting longer than 2 weeks (measured by Insomnia Severity Index with a score greater than 7)
English language fluency
Self reporting stress
Minimum age
18 Years
Maximum age
65 Years
Sex
Both males and females
Can healthy volunteers participate?
No
Key exclusion criteria
1. Patients with a history of a psychological illness or condition that interferes with the patient's ability to understand the requirements of the study.
2. Patients with a history of a psychological illness or condition that requires continuous anti-psychotic medication.
3. Adverse reactions to or inability to digest starch in their diet.
4. Need to have gluten free diet.
5. Women lactating, pregnant or of childbearing potential who are not willing to avoid becoming pregnant during the study.
6. Patients with a history of advanced heart, liver and kidney diseases that is likely to interfere with the metabolism or excretion of the test medication.
7. Patients who had received an investigational new drug within the last 2 weeks.
8. Taking other herbal supplements that may interfere with the herbs in our formulas within the last 2 weeks.
9. Regular alcohol consumption. Consuming > 1 standard drink daily (30ml of spirits, 100ml of wine, or 375ml of strength beer).
10. Need to take over-night shift or early morning shift that requires get up before 6am during the study period.
11. Circumstances or work which forces the participant which prevent them from being in bed by 23:00.
12. Need to travel out of Sydney during the study period.

Study design
Purpose of the study
Treatment
Allocation to intervention
Randomised controlled trial
Procedure for enrolling a subject and allocating the treatment (allocation concealment procedures)
Sealed opaque envelopes
Methods used to generate the sequence in which subjects will be randomised (sequence generation)
Simple randomisation using a randomisation table created by computer software
Masking / blinding
Blinded (masking used)
Who is / are masked / blinded?
The people receiving the treatment/s
The people administering the treatment/s
The people assessing the outcomes
Intervention assignment
Parallel
Other design features
Phase
Phase 2
Type of endpoint/s
Efficacy
Statistical methods / analysis
2 way ANOVA

Recruitment
Recruitment status
Not yet recruiting
Date of first participant enrolment
Anticipated
13/03/2017
Actual
Date of last participant enrolment
Anticipated
28/02/2018
Actual
Date of last data collection
Anticipated
14/03/2018
Actual
Sample size
Target
20
Accrual to date
Final
Recruitment in Australia
Recruitment state(s)
NSW

Funding & Sponsors
Funding source category [1] 295823 0
University
Name [1] 295823 0
University of Technology Sydney
Country [1] 295823 0
Australia
Primary sponsor type
University
Name
University of Technology Sydney
Address
15 Broadway
Ultimo
NSW 2007
Country
Australia
Secondary sponsor category [1] 294671 0
None
Name [1] 294671 0
Address [1] 294671 0
Country [1] 294671 0

Ethics approval
Ethics application status
Approved
Ethics committee name [1] 297106 0
University of Technology Sydney Human Research Ethics Committee
Ethics committee address [1] 297106 0
Ethics committee country [1] 297106 0
Australia
Date submitted for ethics approval [1] 297106 0
05/01/2016
Approval date [1] 297106 0
01/09/2016
Ethics approval number [1] 297106 0
2015000637

Summary
Brief summary
Trial website
Trial related presentations / publications
Public notes

Contacts
Principal investigator
Name 72994 0
Dr Hui Chen
Address 72994 0
Faculty of Science
University of Technology Sydney
15 Broadway
Ultimo
NSW 2007
Country 72994 0
Australia
Phone 72994 0
+61295141328
Fax 72994 0
Email 72994 0
[email protected]
Contact person for public queries
Name 72995 0
Shuai Zheng
Address 72995 0
Faculty of Science
University of Technology Sydney
15 Broadway
Ultimo
NSW 2007
Country 72995 0
Australia
Phone 72995 0
+61295147854
Fax 72995 0
Email 72995 0
[email protected]
Contact person for scientific queries
Name 72996 0
Hui Chen
Address 72996 0
Faculty of Science
University of Technology Sydney
15 Broadway
Ultimo
NSW 2007
Country 72996 0
Australia
Phone 72996 0
+61295141328
Fax 72996 0
Email 72996 0
[email protected]

No information has been provided regarding IPD availability


What supporting documents are/will be available?

No Supporting Document Provided



Results publications and other study-related documents

Documents added manually
No documents have been uploaded by study researchers.

Documents added automatically
No additional documents have been identified.